Weekly updateCompaniesAI-cruiterRecruiting service
Praxis Precision Medicines

Praxis Precision Medicines

  • Founded: 2015

  • Location: Boston, MA

  • Employee range: 50 - 200

  • Clinical stage: Clin2

  • Therapy area: Parkinson's

  • Drug types: NEU, PED

  • Lead product: Ulixacaltamide

  • Product link: https://praxismedicines.com/

  • Funding: $59M stock Jun 2023; $219M IPO Oct 2020; $110M C1 Jul 2020; $100M total May 2020

  • Investors: Blackstone Life Sciences, Novo Holdings, Vida Ventures, Eventide


praxismedicines.com

linkedin.com

job board


Short description:

Genetic Neuroscience Treatments

Drug notes:

Also Clin2 essential tremor; PRAX-562 Clin2 epilepsy; PRAX-628 Clin1 focal epilepsy; PRAX-222 Clin1 epilepsy; 6 programs Clin0 CNS disorders

Long description:

Contact us to add description.

Jobs:


Main
Home

Weekly update

Companies

AI-cruiter

Recruiting service
© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com